Status | Study |
Completed |
Study Name: Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis Condition: Schizophrenia Schizoaffective Disorder Schizophreniform Di Date: 2010-10-04 Interventions: Behavioral: Multi-element, team-oriented treatment Participants will receive treatment and services base |
Completed |
Study Name: Metacognitive Training in Schizophrenia Condition: Delusions Schizophrenia Date: 2009-12-05 Interventions: Behavioral: Metacognitive training |
Completed |
Study Name: Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia Condition: Schizophrenia Date: 2008-08-25 Interventions: Drug: D-cycloserine Single, fi |
Completed |
Study Name: Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia. Condition: Schizophrenia Schizoaffective Disorder Schizophreniform Di Date: 2008-07-14 Interventions: Drug: Risperidone/Olanzapine and PET scans Current risperidone/olanzapine users who are 50 or older will |
Terminated |
Study Name: Anticholinergic Burden in Schizophrenia Condition: Schizophrenia Schizoaffective Disorder Schizophreniform Di Date: 2008-07-11 Interventions: Drug: Benztropine Patients aged ≥ 50 years suffering from a primary psychotic disorder treated wit |
Completed |
Study Name: Acceptance and Commitment Therapy for Delusions Condition: Schizophrenia Delusional Disorder Date: 2008-04-08 Interventions: Behavioral: Acceptance and Commitment Therapy Considered part of the "third wave of CBT" along |
Completed |
Study Name: Cognitive Determinants of Psychoeducation and Information in Psychoses Condition: Schizophrenia Delusional Disorders (ICD-10) Date: 2008-03-25 Interventions: Behavioral: COGPACK training, psychoeducation Bifocal psychoeducation group program (Munich Psychoses In |
Completed |
Study Name: A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis Condition: Schizophrenia Mania Delusional Date: 2008-03-20 Interventions: Drug: Ziprasidone Intramuscular ziprasidone 10 or 20 mg at the investigator's discretion for 1 to 3 days |
Terminated |
Study Name: Schizophrenic Patients Taking Part in Integrated Care Program Condition: Schizophrenia Schizoaffective Disorder Schizophreni-form D Date: 2008-02-05 |
Completed |
Study Name: Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis Condition: Psychotic Disorders Schizophrenia Schizoaffective Disorder Date: 2007-04-25 Interventions: Behavioral: modified cognitive behavioural therapy (mCBT) |